Skip to main content
SpringerLink
Log in

SGLT2-Hemmer deutet Wirksamkeit bei HFpEF an

Durchbruch bei diastolischer Herzinsuffizienz?

  • Report
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Springer Medizin, Neu-Isenburg, Deutschland

    Peter Overbeck

Authors
  1. Peter Overbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Overbeck, P. Durchbruch bei diastolischer Herzinsuffizienz?. MMW - Fortschritte der Medizin 163, 12–13 (2021). https://doi.org/10.1007/s15006-021-0046-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-021-0046-x

Search

Navigation